Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly high-dose liposomal amphotericin B for secondary prophylaxis of invasive mycosis
2006-005030-20Phase 2Completed
- Sponsor
- Istituto Giannina Gaslini
- Start
- Nov 2006
- Modality
- Small Molecules, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of liposomal amphotericin b in invasive mycoses, sponsored by Istituto Giannina Gaslini. Primary endpoint: Safety of weekly high-dose liposomal amphotericin B. Started Nov 2006; status: completed.
02
Drugs
liposomal amphotericin b
03
Conditions
invasive mycoses
Beyond the preview
Go deeper on 2006-005030-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005030-20.